MedTrace Logo

Post Market Clinical Follow-Up TOUCH® CMC 1

NCT06546306 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2025-09-11

No results posted yet for this study

Summary

Because severe pain, weakened pinch and grip strength produce functional disabilities, the basal joint of the thumb is the most common site of surgical reconstruction in the upper limb due to OA.

The cement-free dual mobility Touch® prosthesis consists of a metacarpal implant (stem), a trapezium implant (cup), and a connection implant (neck).

The main objective of this study is to describe the performance and safety of the Touch® prosthesis used with its instruments set in accordance with its intention and CE marking in force.

Performance and safety will be assessed over the short and long term in accordance with the life cycle of the Touch® prosthesis.

Conditions

  • Osteoarthritis Thumb

Interventions

DEVICE

TOUCH® CMC 1

TOUCH® prosthesis is a total CMC 1 (1st Carpo-metacarpal) joint replacement prosthesis.

Sponsors & Collaborators

  • Keri Medical SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-22
Primary Completion
2022-02-22
Completion
2031-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546306 on ClinicalTrials.gov